Biodesix, Inc.
Biodesix, Inc., a leading player in the precision medicine industry, is headquartered in the United States. Founded in 2010, the company has made significant strides in the development of innovative diagnostic solutions, particularly in the field of lung cancer. Biodesix focuses on utilising advanced genomic and proteomic technologies to provide actionable insights for oncologists, enhancing patient care through personalised treatment options. The company’s core offerings include its proprietary blood-based tests, which are designed to identify specific biomarkers associated with lung cancer. This unique approach not only aids in early detection but also helps in tailoring therapies to individual patient profiles. Biodesix has established a strong market position, recognised for its commitment to improving patient outcomes and advancing the field of oncology diagnostics.
DitchCarbon Score
How does Biodesix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biodesix, Inc.'s score of 28 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biodesix, Inc.'s reported carbon emissions
Biodesix, Inc., headquartered in the US, has not publicly disclosed specific carbon emissions data for the most recent year. However, the company is committed to addressing climate change through its participation in the Amazon Climate Pledge, which it signed on 21 March 2022. This commitment signifies Biodesix's intention to work towards achieving net-zero carbon emissions by 2040, aligning with global climate goals. While there are no specific reduction targets or absolute emissions figures available, Biodesix's involvement in the Climate Pledge indicates a proactive approach to sustainability and carbon management. The company is likely focusing on reducing its carbon footprint across various scopes of emissions, including Scope 1, 2, and potentially Scope 3, as part of its broader climate strategy. As the industry increasingly prioritises environmental responsibility, Biodesix's commitment to the Amazon Climate Pledge positions it as a forward-thinking organisation in the life sciences sector, dedicated to mitigating its impact on climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biodesix, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
